Error: Could not add to watchlist. X

Intercept Pharmaceuticals Inc

+ Watchlist
ICPT:US
NASDAQ GS
259.61
USD
4.20
1.59%
As of 20:10:00 ET on 08/04/2015.
Open
261.17
Day Range
256.02 - 265.91
Volume
203,896
Previous Close
263.81
52Wk Range
128.50 - 349.08
1 Yr Return
14.09%
Open
261.17
Day Range
256.02 - 265.91
Volume
203,896
Previous Close
263.81
52Wk Range
128.50 - 349.08
1 Yr Return
14.09%
YTD Return
66.42%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-3.59
Market Cap (b USD)
6.249
Shares Outstanding (m)
24.072
Price/Sales (TTM)
2,025.07
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
ADDRESS
450 West 15th Street
Suite 505
New York, NY 10011
United States
PHONE
1-646-747-1000
  • Luciano Adorini
    Chief Scientific Officer
  • Mark Pruzanski
    President/CEO/Co-Founder
  • Barbara Duncan
    CFO/Treasurer/Secretary
  • Rachel L McMinn
    Chief Strategy Officer
  • David Shapiro
    Exec VP:Dev/Chief Medical Ofcr
Show More